Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in Treatment of Cholestatic and Mixed Drug Induced Liver Injury (DILI)

NCT06019936 is registered in ClinicalTrials.gov with Xi'An Aolitai Pharmaceutical Technology Co Ltd as lead sponsor.

NCT NCT06019936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06019936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in Treatment of Cholestatic and Mixed Drug Induced Liver Injury (DILI)
Lead sponsor
Xi'An Aolitai Pharmaceutical Technology Co Ltd
Phase
Phase 2
Overall status
Unknown status
Start date
August 10, 2023
Completion date
October 10, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholestatic liver injury, drug-induced liver injury, mixed liver injury